On Jul 12, 2021 Biomilk attracted $2 million investments and agreed to collaborate with The Central Bottling Company, also known as Coca-Cola Israel, on research […]
Post-IPO Equity – Adial Pharmaceuticals
On Jul 7, 2021 Adial Pharmaceuticals closed a private placement of 700,001 shares of common stock and raised $5,000,000 from Bespoke Growth Partners, Keystone Capital […]
Seed Round – Allozymes
On Jul 6, 2021 Allozymes closed a Seed round and raised $5,000,000 from Entrepreneur First, HAX, TI Platform Management, Xora Innovation, the round lead by […]
Series C – Standigm
On Jul 6, 2021, Standigm closed a Series C round and raised $10,000,000 from lead investor Pavilion Capital. About the company: Standigm is located in […]
Post-IPO Equity – Spero Therapeutics
On Jun 30, 2021 Spero Therapeutics (Nasdaq: SPRO) announced $40 Million Equity Investment from Pfizer Inc. as part of the Pfizer Breakthrough Growth Initiative, a […]
Series B – Antheia
On Jun 30, 2021 female-founded startup Antheia closed a Series B round and raised $73,000,000 from Hillspire, Sherpalo Ventures, Viking Global Investors. The oversubscribed round […]
Series A – ArriVent Biopharma
On Jun 30, 2021 ArriVent Biopharma closed a Series A round and raised $90,000,000 from Boyu Capital, Hillhouse Capital Group, Lilly Asia Ventures, Lyra Capital, […]
Series A – FabricNano
On Jun 30, 2021 FabricNano closed a Series A round and raised $12,500,000 from Atomico, BACKED VC, BoxOne Ventures, Entrepreneur First, Hoxton Ventures and a […]
Post-IPO Equity – Intellia Therapeutics
On Jun 30, 2021 Intellia Therapeutics (NTLA) announced a public offering of nearly 4.14 million shares and gained $600,000,000 by 2nd July, 2021. About the […]
Series C – Element Biosciences
On Jun 29, 2021 Element Biosciences closed a Series C round and raised $276,000,000 from Counterpoint Global, Fidelity Management and Research Company, Foresite Capital, Janus […]
